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Abstract
Background: To contribute to the development of novel anti-influenza drugs, we investigated the anti-influenza
activity of crude extracts from 118 medicinal plants collected in Myanmar. We discovered that extract from the
stems of Jatropha multifida Linn. showed anti-influenza activity. J. multifida has been used in traditional medicine
for the treatment of various diseases, and the stem has been reported to possess antimicrobial, antimalarial, and
antitumor activities. However, the anti-influenza activity of this extract has not yet been investigated.
Methods: We prepared water (H2O), ethyl acetate (EtOAc), n-hexane (Hex), and chloroform (CHCl3) extracts from
the stems of J. multifida collected in Myanmar, and examined the survival of Madin-Darby canine kidney (MDCK)
cells infected with the influenza A (H1N1) virus, and the inhibitory effects of these crude extracts on influenza A
viral infection and growth in MDCK cells.
Results: The H2O extracts from the stems of J. multifida promoted the survival of MDCK cells infected with the
influenza A H1N1 virus. The EtOAc and CHCl3 extracts resulted in similar, but weaker, effects. The H2O, EtOAc, and
CHCl3 extracts from the stems of J. multifida inhibited influenza A virus H1N1 infection; the H2O extract possessed
the strongest inhibitory effect on influenza infection in MDCK cells. The EtOAc, Hex, and CHCl3 extracts all inhibited
the growth of influenza A H1N1 virus, and the CHCl3 extract demonstrated the strongest activity in MDCK cells.
Conclusion: The H2O or CHCl3 extracts from the stems of J. multifida collected in Myanmar demonstrated the
strongest inhibition of influenza A H1N1 viral infection or growth in MDCK cells, respectively. These results indicated
that the stems of J. multifida could be regarded as an anti-influenza herbal medicine as well as a potential crude
drug source for the development of anti-influenza compounds.
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Background
In 1918, the Spanish influenza A (H1N1) virus pandemic
caused 50 million deaths worldwide [1, 2]. In 2009, influ-
enza A virus originating in swine (H1N1) caused a pan-
demic, and the avian H5N1 and H7N9 influenza A viruses
in China are highly pathogenic to humans [1–4]. Cur-
rently, the application of three antiviral medicines known
as neuraminidase (NA) inhibitors, oral oseltamivir, zana-
mivir, and peramivir, is recommended for the treatment of
influenza. However, oseltamivir resistance has been de-
tected in some of the 2009-derived H1N1 viruses and the
seasonal H1N1 viruses between 2007 and 2009, but little
in H3N2 viruses [5]. In the future, zanamivir- and
peramivir-resistant strains, similar to oseltamivir-resistant
strain, will emerge. Therefore, the development of novel
anti-influenza drugs to prevent and control future influ-
enza epidemics and pandemics is desired.
Traditional medicinal plants have been recognized as a
rich source of candidate compounds for the development
of pharmaceuticals [6, 7]. A large number of natural
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products and extracts from medicinal plants have been re-
ported to possess anti-influenza virus activity [8–10].
Therefore, many studies have focused on traditional medi-
cinal plants as an important source of candidate com-
pounds for the discovery of novel anti-influenza drugs.
The abundance of medicinal plants in Myanmar has en-
abled the population to use traditional medicines to main-
tain their own health and treat various diseases. Thus, to
discover sources for novel anti-influenza drugs, we
screened extracts from 118 medicinal plants collected in
Myanmar to analyze the cell viability of influenza A H1N1
virus (A/PR/8/34)-infected MDCK cells using naphthol
blue black staining. We identified six medicinal plants that
promoted the survival of influenza A virus-infected cells
selected by the criteria described at the Methods section.
Of these six plants, the activity of extract from the stems
of Jatropha multifida Linn (J. multifida) was strongly pro-
nounced. J. multifida, a member of the family Euphorbia-
ceae, is a tree of 2–3 m in height, and widely distributed
in sub-tropical and tropical areas throughout Asia and
Africa [11]. Popularly known as “Say-ma-khan”, it is com-
monly used as a folk medicine in Myanmar and has been
used as a purgative, and against fever, indigestion, colic,
wounds, and skin infection [11]. The seed oil, latex, and
leaves are effective purgatives and abortifacients, have
been used as wound dressings, and for the treatment of
neurodermatitis, eczema, and itches [11]. The roots and
stems have antimicrobial, antimalarial, antitumor, antil-
eishmanial, and antiulcer activities [11, 12]. In addition,
previous phytochemical studies on J. multifida reported
the presence of cyclic peptides, diterpenoids, and phenolic
compounds [11]. However, pharmacological and phyto-
chemical investigations of J. multifida stems originating
from Myanmar have not yet been conducted, which
attracted us to investigate whether extracts from the stems




The stems of J. multifida were purchased from Sandhi
Brothers Trading Co. Ltd (Yangon, Myanmar) in
November 2015. A voucher specimen (TMPW 28729)
was deposited at the Museum of Materia Medica, Ana-
lytical Research Center for Ethnomedicines, Institute of
Natural Medicine, University of Toyama, Japan.
Plant extraction
We performed the plant extraction as described previ-
ously [13, 14]. In brief, dried stems of J. multifida were
chopped into small pieces (3.0 kg), which were macer-
ated four times with 70% aqueous EtOH (7 L) in an
ultrasonic bath for 90 min at 25 °C. After filtration of
the suspension, the resulting solution was evaporated
under reduced pressure to yield a crude extract (180 g).
The crude extract was suspended in water and parti-
tioned into n-hexane (Hex), chloroform (CHCl3), and
ethyl acetate (EtOAc) fractions, to yield Hex-soluble
(12.2 g), CHCl3-soluble (11.0 g), and EtOAc-soluble por-
tions (11.0 g), respectively. Finally, the residual aqueous
layer was evaporated under reduced pressure to yield a
water (H2O)-soluble portion (140.8 g). The extracts were
stored at a concentration of 10 mg/mL in dimethyl sulf-
oxide (DMSO).
Cells
Madin-Darby canine kidney (MDCK) cells were cultured
in high-glucose Dulbecco’s modified Eagle’s medium
(DMEM; Wako, Osaka, Japan), supplemented with 10%
fetal bovine serum (FBS; Life Technologies, CA, USA),
50 units/mL penicillin and 50 μg/mL streptomycin (P/S;
Life Technologies), and 4 mM L-glutamine, at 37 °C in
the presence of 5% CO2 [15].
Viral strain
This study used the Puerto Rico 8/34 (A/PR/8/34;
H1N1) strain of the influenza A virus. Viral titers were
determined by immunostaining influenza A viral nucleo-
protein (NP) as previously described [16].
Analysis of cell viability of influenza A virus-infected
MDCK cells using naphthol blue black staining
MDCK cells were seeded in a 96-well plate (1 × 104
cells/well). H2O, EtOAc, Hex, or CHCl3 extracts from
the stems of J. multifida (0.8-25 μg/mL in DMSO) were
mixed with influenza A virus in 10% FBS-supplemented
growth medium at a multiplicity of infection (MOI) of
10, and then incubated for 30 min at 37 °C in the pres-
ence of 5% CO2. DMSO (0.008-0.5%) and (+)-(S)-baku-
chiol (0.8-25 μM in DMSO) were used as negative and
positive controls, respectively, for the inhibition of influ-
enza A viral infection [15]. The mixture was added to
the cells, which were then incubated for 4 days at 37 °C
in the presence of 5% CO2. After incubation, the cells
were stained using naphthol blue black as previously de-
scribed [15, 17]. The viable cells in each well were
stained blue, while dead cells remained unstained. The
selection criteria for the six plants are more than 50%
cell survival at 96 h after the viral infection with the
concentration of 50 μg/mL.
Thiazolyl blue tetrazolium bromide (MTT) assay
MDCK cells were seeded in each well of a 96-well plate
(1 × 104 cells/well). H2O, EtOAc, Hex, or CHCl3 extracts
(12.5-100 μg/mL) were prepared in DMSO (12.5 μg/mL,
0.125%; 25 μg/mL, 0.25%; 50 μg/mL, 0.5%; 100 μg/mL,
1%) and mixed with infection medium (DMEM supple-
mented with 1% bovine serum albumin [BSA; Wako,
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Osaka, Japan], P/S, and 4 mM L-glutamine). The mixture
was added to the cells, which were then incubated for
24, 72, or 96 h at 37 °C in the presence of 5% CO2. After
incubation, cell viability was determined using the MTT
cell proliferation assay as previously described [15].
Immunofluorescence staining of influenza A virus-
infected cells
MDCK cells were seeded in a 96-well plate (1 × 104 cells/
well). H2O, EtOAc, Hex, or CHCl3 extracts from the
stems of J. multifida (3.1-25 μg/mL) or (+)-(S)-bakuchiol
(3.1-25 μM) were mixed with influenza A virus at a MOI
of 0.1 in the infection medium and incubated for 30 min
at 37 °C in the presence of 5% CO2. DMSO (0.031-0.25%)
was used as the negative control. Each mixture was added
to the cells and incubated for 24 h at 37 °C in the presence
of 5% CO2. The cells were fixed with 4% paraformalde-
hyde in PBS for 30 min at 4 °C and then permeabilized by
the addition of 0.3% Triton X-100 for 20 min at 25 °C. A
mouse antibody for the detection of the NP of A/PR/8/34
(FluA-NP 4 F1; SouthernBiotech, AL, USA) was used as
the primary antibody. Alexa Fluor488-conjugated goat
anti-mouse IgG (H + L) antibody (Life Technologies, CA,
USA) was used as the secondary antibody. Cell nuclei
were then stained using diamidino-2-phenylindole (DAPI;
Life Technologies). The wells were photographed using a
fluorescence microscope (BIOREVO BZ-9000, Keyence,
Osaka, Japan), and the percentage of influenza A NP-
positive cells per DAPI-positive cells were calculated
based on measurements recorded with BZ-H1C software
(Keyence).
Influenza A viral growth assay
To explore whether the extracts from the stems of J.
multifida affected viral growth in pre-infected cells,
MDCK cells were seeded in a 24-well plate (1 × 105
cells/well). The cells were infected with A/PR/8/34
(MOI; 0.001) in infection medium for 1 h at 37 °C in the
presence of 5% CO2. The infected cells were washed
prior to the addition of H2O, EtOAc, Hex, or CHCl3 J.
multifida extracts (12.5 or 25 μg/mL in 0.5% DMSO) to
the cells in infection medium supplemented with 3 μg/
mL L-tosylamido-2-phenyl ethyl chloromethyl ketone
(TPCK)-treated trypsin (Sigma-Aldrich). DMSO (0.5%)
and ribavirin (50 μM in 0.5% DMSO) were the negative
and positive controls, respectively, for the inhibition on
influenza A viral growth [18]. The cells were then incu-
bated for 24, 48, or 72 h at 37 °C in the presence of 5%
CO2. Cell culture media were collected from each well
at predetermined time points. Viral titers (plaque form-
ing units per mL [PFU/mL]) were determined as previ-
ously described [15].
Statistical analysis
All results were expressed as the mean ± the standard
error of the mean (SEM). Differences between more
than two groups were analyzed for statistical significance
by using one-way analysis of variance (ANOVA). Values
of p < 0.05 were considered statistically significant.
Results
Extracts from the stems of J. multifida increased the
survival of influenza A viral-infected MDCK cells
To evaluate the anti-influenza viral activity of extracts
from the stems of J. multifida, we first examined the sur-
vival of influenza A virus-infected MDCK cells after
treatment with the H2O, EtOAc, Hex, or CHCl3 extracts
from the stems of J. multifida. As shown in Fig. 1, cells
exposed to DMSO and infected with A/PR/8/34 were
not stained. However, cells treated with 3.1-25 μM
(+)-(S)-bakuchiol or 3.1-25 μg/mL H2O extract and in-
fected with A/PR/8/34 were stained blue. Cells exposed
to 25 μg/mL EtOAc or 12.5-25 μg/mL CHCl3 extract
and infected with A/PR/8/34 were also weakly stained
blue (Fig. 1).
To evaluate cytotoxicity, we determined the viability of
MDCK cells after incubation for 24, 72, or 96 h in infec-
tion medium containing BSA using the MTT assay
(Fig. 2). The viability of MDCK cells treated with H2O,
EtOAc, Hex, or CHCl3 extract from the stems of J. mul-
tifida was unaffected after 24 h, compared with cells ex-
posed to DMSO only (Fig. 2a). After 72 or 96 h of
incubation, the viability of MDCK cells treated with
100 μg/mL H2O or 12.5-100 μg/mL CHCl3 extracts sig-
nificantly reduced (Fig. 2b), whereas the viability of cells
exposed to ≤ 50 μg/mL H2O, ≤ 100 μg/mL EtOAc and
Fig. 1 Effect of extracts from the stems of J. multifida on the viability
of MDCK cells infected with influenza A H1N1 virus. H2O, EtOAc, Hex,
and CHCl3 extracts from the stems of J. multifida (0.8-25 μg/mL in
DMSO) were mixed with or without (virus-) influenza A H1N1 virus (A/
PR/8/34) (MOI; 10), and added to MDCK cells. DMSO (0.008-0.5%) and
(+)-(S)-bakuchiol (bakuchiol; 0.8-25 μM in DMSO) were used as
negative and positive controls, respectively, for the inhibition of
influenza A viral infection. After incubation for 4 days, cell viability was
determined by naphthol blue black staining. Data are representative of
three independent experiments, and the results were found to
be reproducible
Shoji et al. BMC Complementary and Alternative Medicine  (2017) 17:96 Page 3 of 7
Hex, or ≤ 12.5 μg/mL CHCl3 extracts was unaffected
compared with cells exposed to DMSO only (Fig. 2c).
Therefore, these data suggested that exposure to ≤
100 μg/mL H2O, EtOAc, Hex, or CHCl3 extract for
24 h, or ≤ 50 μg/mL H2O, ≤ 100 μg/mL EtOAc and Hex,
or ≤ 12.5 μg/mL CHCl3 extracts for 72 or 96 h was not
cytotoxic in MDCK cells.
Together, these results proved that the H2O extract
from the stems of J. multifida promoted the survival of
MDCK cells infected with the influenza A H1N1 virus.
The EtOAc and CHCl3 extracts demonstrated similar,
but weaker, effects.
The extracts inhibited influenza A viral infection and
growth
To investigate whether the extracts inhibited viral infec-
tion, we examined viral NP-immunofluorescence stain-
ing in MDCK cells treated with a mixture of virus and
H2O, EtOAc, Hex, or CHCl3 extract for 24 h. The wells
were observed under a microscope and photographed
(Fig. 3a). NP-immunostained cells were counted, and the
percentage of influenza A NP-positive cells per DAPI-
positive cells was calculated (Fig. 3b). The percentage of
influenza A NP-positive cells was significantly decreased
in a concentration-dependent manner in samples treated
with H2O, EtOAc, or CHCl3 extract or (+)-(S)-bakuchiol
(positive control), compared with DMSO-treated cells
(Fig. 3a and b). The H2O extract produced greater inhib-
ition of influenza A viral infection than the other
extracts. These data proved the inhibitory effect of the
Fig. 2 Toxicity of extracts from the stems of J. multifida to MDCK
cells. H2O, EtOAc, Hex, and CHCl3 extracts from the stems of J.
multifida (12.5-100 μg/mL) in DMSO (concentrations of DMSO:
12.5 μg/mL, 0.125%; 25 μg/mL, 0.25%; 50 μg/mL, 0.5%; 100 μg/mL,
1%) were added to the MDCK cells. Cell viabilities were determined
via MTT assay after 24 h (n = 6 each) (a), 72 h (n = 6 each) (b), and
96 h (n = 6 each) (c). Data are the mean ± SEM representative of two
independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001 in
comparison with DMSO
Fig. 3 Extracts from the stems of J. multifida inhibited influenza A
H1N1 viral infection. H2O, EtOAc, Hex, or CHCl3 extracts from the stems
of J. multifida (3.1-25 μg/mL) (n = 9 each) or (+)-(S)-bakuchiol
(bakuchiol; 3.1-25 μM) (n = 9) were mixed with influenza A virus (A/PR/
8/34) at a MOI of 0.1 and added to MDCK cells. DMSO (0.031-0.25%)
(n = 9) was used as the negative control. After 24 h, the cells were
fixed and permeabilized. To visualize influenza A virus-infected cells, we
performed immunofluorescent staining of influenza A viral NP (green)
and cell nuclei (blue), using the nuclear-staining compound, DAPI. Cells
were subsequently photographed under a fluorescence microscope
(a), and the percentage of influenza A viral NP-positive cells per DAPI-
positive cells was calculated based on influenza A viral NP-positive and
DAPI-positive cell numbers (b). The white scale bar in each image
represents 100 μm. Data are presented as means ± SEM of three
independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001 in
comparison with DMSO
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H2O, EtOAc, and CHCl3 extracts from the stems of J.
multifida on influenza A virus H1N1 infection.
Next, we investigated the inhibition of viral growth by
the H2O, EtOAc, Hex, or CHCl3 extract for 24–72 h in
virus-infected MDCK cells. The viral titers in condi-
tioned media from samples treated with CHCl3 extract
between 48 and 72 h, EtOAc or Hex extracts at 72 h,
and ribavirin between 24–72 h were significantly de-
creased compared with those in media conditioned by
DMSO-treated cells (Fig. 4a). However, owing to the
cytotoxicity observed following a 72-h exposure of
MDCK cells to 25 μg/mL CHCl3 extract in the viral
growth experiment (Fig. 2b), we repeated the experiment
with 12.5 μg/mL CHCl3 extract. The viral titers in the
conditioned media from cells treated with 12.5 μg/mL
CHCl3 extract at 48 and 72 h significantly decreased
compared with those in the media conditioned by
DMSO-treated cells (Fig. 4b). These data proved that the
EtOAc, Hex, and CHCl3 extracts inhibited the growth of
influenza A H1N1 virus, and that the CHCl3 extract pos-
sessed the strongest activity.
Together, these results demonstrated the inhibition of
influenza A viral infection and growth by extracts from
the stems of J. multifida. The variation in the inhibitory
effects of the extracts may be due to the polarities of the
phytochemical constituents present in the stems.
Discussion
In the present study, the H2O extract from the stems of
J. multifida strongly increased survival of influenza A
virus-infected MDCK cells (Fig. 1) and inhibited influ-
enza A viral infection (Fig. 3), whereas the CHCl3 extract
demonstrated the strongest inhibition of influenza A
viral growth (Fig. 4) compared with the other crude ex-
tracts. These results indicated that the different polar-
ities of the H2O and CHCl3 crude extracts produced
inhibition of viral infection or growth by different mech-
anisms. Infection with the influenza virus begins with
binding to the surface of a host cell by viral
hemagglutinin (HA), viral surface protein [19]. The in-
fluenza virus invades host cells by endocytosis, and the
viral genome is then released into the host’s cytoplasm
through fusion of the viral membrane with the host
endosomal membrane via HA cleavage. The influenza
viral genome replicates in the host nucleus using viral
RNA polymerase. The virions bud and are released from
the membrane of the host cell using viral NA. In the cell
viability and viral infection assays, the H2O extract from
the stems of J. multifida inhibited influenza A viral bind-
ing to host cells when the influenza virus and extracts
were co-incubated in advance. In contrast, in the viral
growth assay, the CHCl3 extract inhibited influenza A
viral replication in host cells. We therefore propose that
the H2O extract may include compounds that inhibit in-
fluenza A viral binding to host cells surface, endocytosis,
membrane fusion, or uncoating by inhibiting viral HA,
while the CHCl3 extract may include compounds that
inhibit influenza viral replication in host cells by inhibit-
ing viral RNA polymerase or NA activities.
Previously, chemical studies of the stems of J. multi-
fida led to the isolation of lathyrane-type diterpenoids
[20–24], jatrophane-type diterpenoids [11, 22], and
coumarino-type lignoids [22]. The lathyrane-type diter-
penoids, multifidone, multifidanol, and multifidenol,
showed cytotoxicity and antibacterial activity [24]. The
jatrophane-type diterpenoid, jatrophone, was reported to
possess a wide range of biological effects such as
Fig. 4 Extracts from the stems of J. multifida inhibited influenza A
H1N1 viral growth. MDCK cells were infected with A/PR/8/34 (MOI;
0.001) for 1 h, and then the infected cells were washed. H2O, EtOAc,
Hex, or CHCl3 extracts from the stems of J. multifida (25 μg/mL in 0.5%
DMSO) (n = 7 each) (a) were added to the cells in the infection
medium supplemented with 3 μg/mL TPCK-treated trypsin. DMSO
(0.5%) (n = 7) or ribavirin (50 μM in 0.5% DMSO) (n = 7) were the
negative and positive controls, respectively, for the inhibition of influenza
A viral growth. In addition, the same experiment was performed with
DMSO (0.5%), ribavirin (50 μM in 0.5% DMSO), and 12.5 μg/mL CHCl3-
extract from the stems of J. multifida (in 0.5% DMSO) (n= 12 each)
(b). The conditioned culture medium was collected at the indicated time
points, added to MDCK cells, and the treated cells were immunostained
with an antibody to influenza A viral NP. The viral titers (PFU/mL) were
calculated from the number of stained cells. The data are the mean ±
SEM representative of three independent experiments. *p< 0.05; **p<
0.01; ***p< 0.001 in comparison with DMSO
Shoji et al. BMC Complementary and Alternative Medicine  (2017) 17:96 Page 5 of 7
cytotoxicity and antitumor activity [25, 26]. However,
the anti-influenza activity of the phytochemical constitu-
ents of J. multifida has not been yet investigated. The
lathyrane-type diterpenoids from Euphorbia micractina
showed the anti-HIV activity [27]. Dang et al. recently
reported that the abietane-type tricyclic phenolic diter-
penoids, (+)-podcarpic acid and (+)-totarol, inhibited in-
fluenza A H1N1 viral infection (A/PR/8/34) [28].
Therefore, the diterpenoids contained in J. multifida
may confer the anti-viral effects such as anti-influenza
and anti-HIV activities. It is expected that anti-influenza
compounds will be isolated from the active crude
extracts in our ongoing work.
Conclusions
The findings of the present study demonstrated that the
most polar extract, the H2O extract, from the stems of J.
multifida increased survival of MDCK cells infected with
the influenza A H1N1 virus and showed the strongest
inhibition of influenza A H1N1 viral infection in MDCK
cells. Of the EtOAc, Hex, and CHCl3 extracts, the
CHCl3 extract showed the strongest inhibition of influ-
enza A H1N1 viral growth in MDCK cells. These results
indicated that the stems of J. multifida could be used as
a herbal medicine for the treatment of influenza and
may be a source of candidate compounds for novel anti-
influenza drug development.
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